PNPLA3 rs738409 polymorphism is associated with liver fibrosis progression in patients with chronic hepatitis C: A repeated measures study
The natural course of chronic hepatitis C (CHC) varies widely among individuals [1], and the early recognition of patients at risk for developing liver fibrosis and cirrhosis is essential to take preventive measures that may affect the course of CHC [2]. Several risk factors have been associated with liver fibrosis progression, including age at infection, sex, route of infection, hepatitis C virus (HCV) genotype, and obesity among others [3]. In this regard, single nucleotide polymorphisms have been also associated with liver disease progression [3,4].
Source: Journal of Clinical Virology - Category: Virology Authors: Mar ía Ángeles Jiménez-Sousa, Ana Zaida Gómez-Moreno, Daniel Pineda-Tenor, Juan José Sánchez-Ruano, Amanda Fernández-Rodríguez, Tomas Artaza-Varasa, Alicia Gómez-Sanz, María Martín-Vicente, Sonia Vázquez-Morón, Salvador Resino Tags: Short communication Source Type: research
More News: Cirrhosis | Eating Disorders & Weight Management | Hepatitis | Hepatitis C | Liver | Liver Disease | Obesity | Study | Urology & Nephrology | Virology